Test Might Predict Risk of Lung Cancer’s Return (HealthDay)

Your Health Matters

HealthDay – THURSDAY, Jan. 26 (HealthDay News) — A new industry-funded study
suggests that a molecular test can provide insight into whether patients
are at high risk of a relapse after surgical treatment for a form of lung
cancer.

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave